View All Documents & Correspondence
An Anti Ageing Oral Formulation To Slow Down Ageing Process And Amethod To Make It
Abstract: The invention relates to a stable oral liquid formulation developed for treating negative effects of Advanced Glycation end Products (AGEs) in a clear oral liquid formulation containing Resveratrol, Benfotiamine, Pyridoxamine and one or more pharmaceutically active agents in a suitable vehicle and an effective amount of solubilizer. The solubilizer may include Povidone, Polyoxyl 40 hydrogenated castor oil but not limited to these wherein the solubilizer enhances solubility of Resveratrol in water and stabilizes the Benfotiamine and Pyridoxamine in the formulation along with Resveratrol. The process of making the formulation is unique. It may be used for treatment and prevention of conditions and diseases including many degenerative diseases, such as diabetes, atherosclerosis, chronic renal failure caused due to AGEs and formation of Advanced Lipoxidation End Products (ALEs).
Notices, Deadlines & Correspondence
Patent Information
Applicants
Apex Laboratories Private Limited
Inventors
1. Sulur, Subramaniam Vanangamudi
2. Srinivasan, Murali
3. Srinivasan, Madhavan
4. Gopalakrishnan, Sivaraman
Specification
DESC:Complete specification is attached ,CLAIMS:Claims are attached along with complete specification
Documents
Orders
| Section | Controller | Decision Date |
|---|---|---|
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 6229-CHE-2014-HearingNoticeLetter-(DateOfHearing-20-01-2020).pdf | 2020-01-06 |
| 1 | Provisional specification_for PO.pdf | 2014-12-11 |
| 2 | Form 3.pdf | 2014-12-11 |
| 2 | 6229-CHE-2014-CLAIMS [05-02-2019(online)].pdf | 2019-02-05 |
| 3 | Form 26.pdf | 2014-12-11 |
| 3 | 6229-CHE-2014-ENDORSEMENT BY INVENTORS [05-02-2019(online)].pdf | 2019-02-05 |
| 4 | 6229-CHE-2014-FER_SER_REPLY [05-02-2019(online)].pdf | 2019-02-05 |
| 4 | 6229-CHE-2014 POWER OF ATTORNEY 19-02-2015.pdf | 2015-02-19 |
| 5 | 6229-CHE-2014-PETITION UNDER RULE 137 [05-02-2019(online)].pdf | 2019-02-05 |
| 5 | 6229-CHE-2014 FORM-1 19-02-2015.pdf | 2015-02-19 |
| 6 | 6229-CHE-2014-RELEVANT DOCUMENTS [05-02-2019(online)].pdf | 2019-02-05 |
| 6 | 6229-CHE-2014 CORRESPONDENCE OTHERS 19-02-2015.pdf | 2015-02-19 |
| 7 | REQUEST FOR CERTIFIED COPY [09-12-2015(online)].pdf | 2015-12-09 |
| 7 | 6229-CHE-2014-FER.pdf | 2018-08-29 |
| 8 | Drawing [09-12-2015(online)].pdf | 2015-12-09 |
| 8 | Description(Complete) [09-12-2015(online)].pdf | 2015-12-09 |
| 9 | Drawing [09-12-2015(online)].pdf | 2015-12-09 |
| 9 | Description(Complete) [09-12-2015(online)].pdf | 2015-12-09 |
| 10 | 6229-CHE-2014-FER.pdf | 2018-08-29 |
| 10 | REQUEST FOR CERTIFIED COPY [09-12-2015(online)].pdf | 2015-12-09 |
| 11 | 6229-CHE-2014-RELEVANT DOCUMENTS [05-02-2019(online)].pdf | 2019-02-05 |
| 11 | 6229-CHE-2014 CORRESPONDENCE OTHERS 19-02-2015.pdf | 2015-02-19 |
| 12 | 6229-CHE-2014-PETITION UNDER RULE 137 [05-02-2019(online)].pdf | 2019-02-05 |
| 12 | 6229-CHE-2014 FORM-1 19-02-2015.pdf | 2015-02-19 |
| 13 | 6229-CHE-2014-FER_SER_REPLY [05-02-2019(online)].pdf | 2019-02-05 |
| 13 | 6229-CHE-2014 POWER OF ATTORNEY 19-02-2015.pdf | 2015-02-19 |
| 14 | Form 26.pdf | 2014-12-11 |
| 14 | 6229-CHE-2014-ENDORSEMENT BY INVENTORS [05-02-2019(online)].pdf | 2019-02-05 |
| 15 | Form 3.pdf | 2014-12-11 |
| 15 | 6229-CHE-2014-CLAIMS [05-02-2019(online)].pdf | 2019-02-05 |
| 16 | Provisional specification_for PO.pdf | 2014-12-11 |
| 16 | 6229-CHE-2014-HearingNoticeLetter-(DateOfHearing-20-01-2020).pdf | 2020-01-06 |
Search Strategy
| 1 | 6229search_31-07-2018.pdf |